In the RLAY stock forecast, institutional inflows have increased by 8% over the past month, signaling confidence in the company’s pipeline. The biotech sector shows above-average earnings revisions, and macro trends point toward sustained demand for AI-powered drug discovery. For example, Seabridge Gold posted a $5.3 million net loss during Q3 of 2023. A year prior, it posted $5 million in net income. Ultimately, investing in mining exploration companies is simply a gamble. The company ended first-quarter 2025 with a cash balance of $509 million, which is expected to fuel operations into mid-2027 based on its current business plan. RLAY stock forecast underlines that volatility remains within safe bounds compared to its peers. Options market pricing signals investor expectations of a gradual rally, with implied volatility at 32%.